Longer leash on life: Inside the dog longevity startup

What if dogs could live longer and healthier lives? Loyal’s Celine Halioua has raised $135 million from top investors to develop canine longevity pills—and expects to get her first conditional approval from the FDA next year. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Dogs don’t live […]

How Square Peg’s Paul Bassat is picking the next AI giants

SEEK co-founder Paul Bassat built Square Peg into a venture capital powerhouse. His latest bets are on AI, Thinking Machines Lab, and the non-partisan Amplify, which tackles housing and equity challenges.    This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Paul Bassat’s 2025 investment in Mira Murati’s $18.5 […]

Inside Antler’s £100 million revival plan

Once stripped back to a dormant website, Antler is now reclaiming its place in the $86 billion luggage industry, guided by heritage rather than hype. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. Among the glamorous luggage spinning endlessly on airport carousels, the competition has never been […]

How this new biotech billionaire outmanoeuvred Merck in China

Michelle Xia gained experience at U.S. pharmaceutical firms before launching her own biotech company back home in China. In a trial last year, the firm’s cancer drug outperformed the world’s best seller–and its surging stock just made her a billionaire. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your […]

The Australian startup turning living cells into computer code

Cell Bauhaus is building computer-based replicas of living systems to accelerate bioengineering. By modelling entire cells, it aims to recast biology as a discipline of digital design, rather than trial-and-error. This story appears in Issue 19 of Forbes Australia, out now. Tap here to secure your copy. After years of watching academic breakthroughs stall before reaching […]